Detalhe da pesquisa
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med;
390(15): 1394-1407, 2024 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38587233
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med;
389(12): 1069-1084, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37622681
3.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Circulation;
149(3): 204-216, 2024 01 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37952180
4.
Optimising health after early menopause.
Lancet;
403(10430): 958-968, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38458215
5.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet;
403(10437): 1635-1648, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38599221
6.
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J;
2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38739118
7.
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.
Lancet;
402(10403): 720-730, 2023 08 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37364590
8.
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
N Engl J Med;
385(6): 503-515, 2021 08 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34170647
9.
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
N Engl J Med;
384(11): 989-1002, 2021 03 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33567185
10.
What is the pipeline for future medications for obesity?
Int J Obes (Lond);
2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38302593
11.
Cardio-renal-metabolic disease in primary care setting.
Diabetes Metab Res Rev;
40(3): e3755, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38115715
12.
Real-world study of the concomitant use of biphasic insulin aspart 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes.
Diabet Med;
41(5): e15267, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38088483
13.
Twenty-four-hour physical behaviour profiles across type 2 diabetes mellitus subtypes.
Diabetes Obes Metab;
26(4): 1355-1365, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38186324
14.
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real-world observational study.
Diabetes Obes Metab;
26(2): 512-523, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37857573
15.
Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta-analysis of cardiovascular outcome trials of novel glucose-lowering agents.
Diabetes Obes Metab;
26(5): 1837-1849, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38379094
16.
Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes.
BMC Cardiovasc Disord;
24(1): 25, 2024 01 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38172712
17.
Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus.
Age Ageing;
53(5)2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38706394
18.
Translating trial results into interpretable risk estimates: Systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.
Nutr Metab Cardiovasc Dis;
34(5): 1129-1133, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38336546
19.
Long-term ambient air pollution exposure and prospective change in sedentary behaviour and physical activity in individuals at risk of type 2 diabetes in the UK.
J Public Health (Oxf);
46(1): e32-e42, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38103023
20.
Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial.
Ann Intern Med;
176(11): 1476-1485, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37748181